Date |
SE trades |
Over-the-counter |
||||||
---|---|---|---|---|---|---|---|---|
DVP | No. of securities units | Total nominal value | Turnover(EUR) | DVP | FOP | No. of securities units | Total nominal value | |
2021 April | 1 | 1,000 | ||||||
2021 March | 6 | 1,546,200 | ||||||
2021 February | 1 | 584,000 | ||||||
2021 January | 3 | 1 | 1,219,000 | |||||
2020 December | 11 | 661,300 | ||||||
2020 November | 11 | 1,064,000 | ||||||
2020 October | 2 | 10,000 | ||||||
2020 September | 1 | 1 | 1,000,000 | |||||
2020 July | 4 | 20,000 | ||||||
2020 June | 2 | 65,600 | ||||||
2020 May | 5 | 12,020,000 | ||||||
2020 April | 7 | 1 | 26,923,000 | |||||
2020 March | 3 | 5,511,200 | ||||||
2019 December | 4 | 2 | 8,230,000 | |||||
2019 September | 1 | 355,000 | 357,850 | 1 | 1 | 455,000 | ||
2019 August | 1 | 100,000 | ||||||
2019 July | 6 | 4,990,000 | ||||||
2019 June | 4 | 2 | 8,339,600 | |||||
2019 May | 1 | 467,500 | ||||||
2019 April | 28 | 33,023,400 | ||||||
2019 March | 5 | 2,570,000 | ||||||
2019 February | 11 | 38,000,000 | 38,337,488 | 15 | 16,869,600 | |||
2019 January | 7 | 3 | 22,411,500 | |||||
2018 December | 3 | 67,300 | ||||||
2018 November | 2 | 1 | 1,550,500 | |||||
2018 October | 1 | 11,000 | 11,071 | 7 | 1 | 9,713,100 | ||
2018 September | 1 | 2 | 424,500 | |||||
2018 August | 1 | 700,000 | ||||||
2018 July | 1 | 2 | 885,000 | |||||
2018 June | 2 | 200,000 | ||||||
2018 May | 7 | 2 | 17,290,200 | |||||
2018 April | 2 | 1,424,000 | ||||||
2018 March | 7 | 3,800,000 | ||||||
2018 February | 1 | 1 | 30,002,900 | |||||
2017 December | 1 | 1 | 3,027,100 | |||||
2017 November | 2 | 1 | 18,355,000 |
Please note that settlement statistics part of the website only contains information about settled transactions starting from September 18, 2017 for Estonian, Latvian, and Lithuanian markets, and starting from August 24, 2020 - for Estonian, Latvian, Lithuanian and Icelandic markets.
The use of information contained on Nasdaq CSD website is governed by the Terms and Conditions. The use of statistical data for commercial purposes is the subject to additional fees. Please contact csd@nasdaq.com to receive further information.